Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents
Which is advantageous for identification: antigen, CDR, cross-reactivity, or hybridoma?
★What constitutes a strong patent specification and claims when acquiring rights for antibody drugs? ★Along with essential practical knowledge, we will teach you claim techniques that your company may not know, incorporating exercises! 【Instructor】Akihiko Okuno, Representative Employee, SK Patent Firm, Patent Attorney 【Venue】Tekuno Kawasaki, 5th Floor, Room 5 Training 【Kanagawa, Musashi-Mizonokuchi Station】 【Date and Time】November 29, 2010 (Monday) 13:00–16:00 【Lecture ends at 16:00. 16:00-16:30: Free Time Q&A】
- Company:AndTech
- Price:10,000 yen-100,000 yen